Kinarus Therapeutics Holding AG
SIX:KNRS
Cash Flow Statement
Cash Flow Statement
Kinarus Therapeutics Holding AG
| Jun-2021 | Dec-2021 | Jun-2022 | Dec-2022 | Jun-2023 | Dec-2023 | ||
|---|---|---|---|---|---|---|---|
| Operating Cash Flow | |||||||
| Net Income |
(0)
|
(0)
|
(1)
|
(35)
|
(36)
|
(14)
|
|
| Depreciation & Amortization |
(0)
|
0
|
0
|
2
|
2
|
0
|
|
| Other Non-Cash Items |
(0)
|
(0)
|
(0)
|
40
|
40
|
13
|
|
| Cash Interest Paid |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Change in Working Capital |
(0)
|
0
|
(0)
|
0
|
1
|
0
|
|
| Cash from Operating Activities |
(0)
N/A
|
(0)
+19%
|
(1)
-279%
|
(0)
+69%
|
(1)
-106%
|
(1)
+39%
|
|
| Investing Cash Flow | |||||||
| Capital Expenditures |
0
|
0
|
0
|
(0)
|
0
|
0
|
|
| Other Items |
0
|
0
|
5
|
5
|
0
|
0
|
|
| Cash from Investing Activities |
0
N/A
|
0
N/A
|
5
N/A
|
5
0%
|
(0)
N/A
|
0
N/A
|
|
| Financing Cash Flow | |||||||
| Net Issuance of Debt |
0
|
0
|
0
|
0
|
1
|
1
|
|
| Other |
0
|
0
|
(0)
|
(0)
|
(0)
|
0
|
|
| Cash from Financing Activities |
0
N/A
|
0
-3%
|
0
-30%
|
0
+3%
|
1
+91%
|
1
-9%
|
|
| Change in Cash | |||||||
| Effect of Foreign Exchange Rates |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Net Change in Cash |
0
N/A
|
0
+2 950%
|
4
+7 134%
|
5
+22%
|
(0)
N/A
|
(0)
+100%
|
|
| Free Cash Flow | |||||||
| Free Cash Flow |
(0)
N/A
|
(0)
+19%
|
(1)
-279%
|
(0)
+69%
|
(1)
-104%
|
(1)
+39%
|
|